retatrutide considerations Retatrutide is a newer triple agonist (GIP, GLP-1, and glucagon) that is still in clinical trials
Signal Amplification: Activated receptors trigger G-protein coupling, adenylyl cyclase activation, and dramatic increases in intracellular cAMP (often 10-100 fold elevation)
Most therapeutic peptides exceed these thresholds
For instance, if your target measurement is 300 mcg: With a 2.0 mL mix (2.5 mg/mL), you would draw exactly 12 units (0.12 mL)
However, complete healing of significant labral tears likely requires surgical intervention
In contrast, IM injections can be painful, and are more error-prone than injecting into fat